METTL3 and cancer: Recent studies indicated that m6A modifications of mRNAs are increased in cancer cells during EMT, and that deletion of the m6A writer, METTL3, can impair EMT, while deletion of the m6A eraser, FTO, can promote EMT [16, 17].